Published! Psychedelic Medicines For Primary Care

As published in the American Journal of Therapeutics

I am pleased to share that the American Journal of Therapeutics Special Issue on Psychedelic Therapy: A Primer for Primary Care Clinicians has just been published!  This is a publication aimed to educate doctors of all backgrounds on psychedelics as therapeutics.  This series was guest edited by Burton Tabaac, Kenneth Shinozuka, and myself. My dear friend, of many years now—and the coauthor of my first paper ever!—is the editor of the journal, and it’s been a delight to have his collaboration throughout the preparation of these manuscripts.

The sections are as follows:

Historical Perspective and Overview

Lysergic Acid Diethylamide (LSD)

N,N-Dimethyltryptamine and Ayahuasca

Psilocybin

Ibogaine

3,4-Methylenedioxy-methamphetamine (MDMA)

Ketamine

The Strengths, Weaknesses, Opportunities, and Threats of Psychedelic Therapeutics

There is also a Commentary authored by Dr. Lynn Marie Morski, MD, JD, the President of the Psychedelic Medicine Association.

The series abstracts and journal information can …